R.D. Callander

Mechanistic relationship among mutagenicity, skin sensitization, and skin carcinogenicity.

J. Ashby, Jennifer Hilton, R.J. Dearman et al. · Environmental Health Perspectives · 1993 · 48 citations · Full text

Pharmacy, Dermatology, Toxicology +17

potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: Comparison to salmonella responses

J. Ashby, H. Tinwell, Paul Glover et al. · Environmental and Molecular Mutagenesis · 1994 · 47 citations

Pharmacy, Molecular Biology, Toxicology +16

The mutagenicity testing of tertiary-butyl alcohol, tertiary-butyl acetate™ and methyl tertiary-butyl ether in Salmonella typhimurium

Douglas McGregor, George Cruzan, R.D. Callander et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2004 · 43 citations

Pharmacy, Microbiology, Toxicology +5

Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species and therapy areas

Steve Horner, David P. Ryan, Sally Robinson et al. · Regulatory Toxicology and Pharmacology · 2013 · 42 citations

Pharmacy, Pharmacology, Toxicology +15

Evaluation of phenobarbital/β-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in <i>in vitro</i> genotoxicity assays

R.D. Callander, J.M. Mackay, P. Clay et al. · Mutagenesis · 1995 · 41 citations

Pharmacy, Pharmacology, Toxicology +15